Sichuan Kelun Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -15.48% vs -0.95% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -81.44% vs 24.73% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,193.40",
          "val2": "4,961.70",
          "chgp": "-15.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "154.30",
          "val2": "1,133.40",
          "chgp": "-86.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "30.00",
          "val2": "34.10",
          "chgp": "-12.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.30",
          "val2": "8.20",
          "chgp": "-23.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "130.90",
          "val2": "705.20",
          "chgp": "-81.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.80%",
          "val2": "160.80%",
          "chgp": "-12.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.69% vs 12.64% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 27.03% vs 55.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21,619.40",
          "val2": "21,259.30",
          "chgp": "1.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,141.30",
          "val2": "4,537.70",
          "chgp": "13.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "154.70",
          "val2": "370.70",
          "chgp": "-58.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.50",
          "val2": "-39.30",
          "chgp": "37.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,362.00",
          "val2": "2,646.60",
          "chgp": "27.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "177.80%",
          "val2": "154.20%",
          "chgp": "2.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

4,193.40

4,961.70

-15.48%

Operating Profit (PBDIT) excl Other Income

154.30

1,133.40

-86.39%

Interest

30.00

34.10

-12.02%

Exceptional Items

6.30

8.20

-23.17%

Consolidate Net Profit

130.90

705.20

-81.44%

Operating Profit Margin (Excl OI)

36.80%

160.80%

-12.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is -15.48% vs -0.95% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -81.44% vs 24.73% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

21,619.40

21,259.30

1.69%

Operating Profit (PBDIT) excl Other Income

5,141.30

4,537.70

13.30%

Interest

154.70

370.70

-58.27%

Exceptional Items

-24.50

-39.30

37.66%

Consolidate Net Profit

3,362.00

2,646.60

27.03%

Operating Profit Margin (Excl OI)

177.80%

154.20%

2.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 1.69% vs 12.64% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 27.03% vs 55.30% in Dec 2023

All Annual Results